RenovoRx (RNXT) just unveiled an update.
On April 11, 2024, the Company successfully completed a notable private placement offering, raising $11.1 million in gross proceeds. This strategic financial move involved the issuance of nearly 7 million shares, along with various series of warrants that provide options to acquire additional shares in the future. The funds are earmarked for working capital, with an expected net gain of $9.6 million after expenses. The offering attracted around 170 accredited investors, underscoring the Company’s solid position in the financial market and its commitment to growth and operational funding.
For an in-depth examination of RNXT stock, go to TipRanks’ Stock Analysis page.
